Horizon Therapeutics Public Limited Company

DB:HPR 주식 보고서

시가총액: €25.3b

Horizon Therapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.


소유권 분석

HPR 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업3,0290.00132%
주 또는 정부104,8640.0458%
개인 내부자379,2340.166%
일반 대중9,585,3024.19%
헤지 펀드12,726,9005.56%
교육기관206,195,23990%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.


최대 주주

상위 25 주주가 회사의 59.52%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
9.41%
The Vanguard Group, Inc.
21,544,524€2.4b-0.04%0.05%
6.48%
BlackRock, Inc.
14,841,177€1.6b-0.42%0.04%
5.56%
Pentwater Capital Management LP
12,726,900€1.4b109%19.7%
3.11%
UBS O'Connor LLC
7,124,969€787.1m63.7%35.35%
3.06%
Avoro Capital Advisors LLC
7,000,000€773.3m0%12.34%
2.62%
HBK Investments L.P.
6,000,000€662.8m1.69%74.91%
2.3%
State Street Global Advisors, Inc.
5,274,052€582.6m2.97%0.03%
2.3%
JPMorgan Chase & Co, Brokerage and Securities Investments
5,271,269€582.3m-0.71%0.44%
2.06%
D. E. Shaw & Co., L.P.
4,717,646€521.2m28.1%0.98%
1.97%
Millennium International Management LP
4,520,705€499.4m4.94%102.1%
1.95%
Citadel Advisors LLC
4,463,101€493.1m12.2%0.67%
1.85%
Norges Bank Investment Management
4,245,009€469.0m0.69%0.05%
1.83%
Davidson Kempner Capital Management LP
4,193,486€463.3m-6.36%19.16%
1.77%
Millennium Management LLC
4,058,491€448.4m-5.79%0.52%
1.51%
Renaissance Technologies LLC
3,448,749€381.0m2.38%0.6%
1.5%
Adage Capital Management, L.P.
3,427,925€378.7m14.5%0.89%
1.44%
Geode Capital Management, LLC
3,301,561€364.7m0.73%0.04%
1.44%
Soros Fund Management LLC
3,291,801€363.7m0%14.36%
1.31%
Fidelity International Ltd
3,003,963€331.9m1.24%0.17%
1.17%
Franklin Resources, Inc.
2,690,055€297.2m11.3%0.13%
1.07%
Morgan Stanley, Investment Banking and Brokerage Investments
2,458,323€271.6m70.8%0.05%
0.99%
Deutsche Asset & Wealth Management
2,274,568€251.3m14.7%0.15%
0.99%
Westchester Capital Management, LLC
2,257,464€249.4m10.5%13.76%
0.93%
Taconic Capital Advisors L.P.
2,130,000€235.3m5.06%24.08%
0.89%
BNY Mellon Asset Management
2,039,156€225.3m-3.96%0.05%